Domino transplantation using livers from patients with familial amyloidotic polyneuropathy: Should we halt?

Liver Transplantation

Volumn 13, Issue 2, 2007, Pages 185-187

  Ericzon, Bo Göran ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; DIURETIC AGENT; PREALBUMIN;

CLINICAL FEATURE; DISEASE CONTROL; DISEASE COURSE; DISEASE TRANSMISSION; DONOR SELECTION; EDITORIAL; FAMILIAL AMYLOID POLYNEUROPATHY; GENE MUTATION; GENETIC DISORDER; GRAFT RECIPIENT; HUMAN; HYPEROXALURIA; INFLAMMATION; LIVER CANCER; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; NEPHROLITHIASIS; ONSET AGE; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; TISSUE DISTRIBUTION; TREATMENT INDICATION; TREATMENT OUTCOME; VIRUS REACTIVATION;

AMYLOID NEUROPATHIES, FAMILIAL; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; TISSUE AND ORGAN PROCUREMENT;

EID: 33847688377     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.21073     Document Type: Editorial

References (10)

1. Holmgren G, Steen L, Ekstedt J, Groth CG, Ericzon BG, Eriksson S, et al. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991:40:242-246.
2. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993;341:1113-1116.
3. Ericzon BG, Suhr O, Broome U, Holmgren G, Duraj F, Eleborg L, et al. Liver transplantation halts the progress of familial amyloidotic polyneuropathy. Transplant Proc 1995:27:1233.
4. Coutinho P, Martins da Silva, Lopes Lima J, Resende Barbosa A. Forty years of experience with type 1 amyloid neuropathy. Review of 483 cases. In: Glenner GG, Pinho e Costa P, Falcao de Freitas A, eds. Amyloid and Amyloidosis. Amsterdam: Excerpta Medica, 1980:88-98.
5. Furtado AJ. Domino liver transplantation using FAP grafts. HUC experience-hopes and realities. Amyloid 2004; 10(Suppl 1):84-87.
6. Donckier V, El Nakadi I, Closset J, Ickx B, Louis H, Le Moine O, et al. Domino hepatic transplantation using the liver from av patient with primary hyperoxularia. Transplantation 2001;71:1346-1348.
7. Farese S, Trost N, Candinas D, Huynh-Do U. Early renal failure after domino hepatic transplantation using the liver from av compound heterozygous patient with primary hyperoxaluria. Nephrol Dial Transplant 2005;20:2557-2560.
8. Sousa MM, Ferrao J, Fernandes R, Guimaraes A, Geraldes JB, Perdigoto R, et al. Deposition and passage of tranthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers. Lab Invest 2004;84: 865-873.
9. Stangou AJ, Heaton ND, Hawkins PN. Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. N Engl J Med 2005;352: 2356.
10. Goto T, Yamashita T, Ueda M, Ohshima S, Yoneyama K, Nakamura M, et al. Iatrogenic amyloid neuropathy in a Japanese patient after sequential liver transplantation. Am J Transplant 2006;6:2512-2515.